| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.09B | +10.1% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | +19.3% |
| Gross margin | 58.1% | Net margin 31.1% |
| Revenue Q/Q | +14.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.04B | 41.9% |
| R&D | ¥0.00B | 5.1% |
| SG&A | ¥0.01B | 14.6% |
| Tax & other | ¥0.00B | 5.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
东星医疗 ・ 明阳电气 ・ 海科新源 ・ 三博脑科 ・ 美硕科技 ・ 新巨丰 ・ 富乐德 ・ 东利机械 ・ 卓创资讯 ・ 远翔新材 ・ 川宁生物 ・ 华如科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies